Skip to main content
915 TLDR
Health
1 read

White House Addresses Rumors on Trump's Access to Eli Lilly's Obesity Drug

KTSM••Ashleigh Fields and The Hill
Medical stethoscope representing healthcare news

Want the full story?

Read the complete article at KTSM

Read Original

AI Summary

The White House has clarified that speculation regarding former President Donald Trump's access to the experimental obesity drug retatrutide, produced by Eli Lilly, is unfounded. Although the drug is not yet approved by the FDA, it can be accessed through a compassionate use program for patients with life-threatening conditions. This clarification is significant as it highlights the ongoing discussions around drug access and approval processes, particularly for high-profile individuals. The compassionate use program allows for limited access to unapproved treatments, but it is not indicative of broader availability.

health trump obesity eli-lilly drug-access

People & Organizations

Donald TrumpEli Lilly

Related Articles

KTSM•Jul 9

Health Experts Warn of Rising Parasite Threat Causing Severe Diarrhea

Health officials are sounding the alarm as cases of a parasite known to cause severe gastrointestinal issues, including explosive diarrhea, are on the rise across the United States. This increase poses a significant health risk, prompting experts to advise the public on preventive measures to avoid infection. Residents are encouraged to stay informed about hygiene practices and food safety to protect themselves from this threat. The situation underscores the importance of vigilance as the parasite spreads.

Health
1 min read
KVIA•Jul 9

Study Reveals Social Media's Impact on Health Decisions Among Americans

A recent study published in JAMA highlights that over 20% of U.S. adults using social media have made health decisions based on information found online. This translates to approximately 47 million individuals influenced by social media for health-related choices. While social media offers quick and accessible health information, nearly 78% of users express skepticism about its accuracy. The study, which surveyed over 7,270 adults, indicates that both healthy individuals and those with chronic conditions rely on these platforms for health insights. Experts caution that misinformation can spread easily, and users should critically evaluate the sources of health information they encounter online.

Health
1 min read
KTSM•Jul 9

Nationwide Recall of Eye Drops Affects Millions Due to Contamination Risk

A significant recall of eye drop products has been issued by the Food and Drug Administration, impacting millions of bottles across the United States. These eye drops, commonly used for treating allergies and inflammation, may contain a foreign substance that poses health risks to users. This recall highlights the importance of consumer safety and the need for vigilance when using over-the-counter medications. Affected individuals should check their medicine cabinets and discontinue use of the recalled products immediately.

Health
1 min read
KTSM•Jul 8

Immunize El Paso Increases Hours for Back-to-School Vaccinations

In preparation for the upcoming school year, Immunize El Paso is extending its operating hours to accommodate the rising demand for vaccinations. This initiative is crucial for ensuring that both children and adults receive necessary immunizations. The organization is part of the Texas Vaccines for Children (TVFC) Program, which assists eligible families in accessing affordable vaccines. Families are encouraged to take advantage of these extended hours to ensure their children are up-to-date on immunizations before school starts.

Health
1 min read